Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice.
Saved in:
| Title: | Novel EGFRvIII-CAR transgenic mice for rigorous preclinical studies in syngeneic mice. |
|---|---|
| Authors: | Chuntova P; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Hou Y; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Naka R; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Japanese Red Cross Osaka Hospital, Osaka City, Japan., Yamamichi A; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Chen T; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Goretsky Y; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Hatae R; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Nejo T; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Kohanbash G; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Department of Neurological Surgery, University of Pittsburgh, Pittsburgh, Pennsylvania, USA., Mende AL; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Montoya M; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Downey KM; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Diebold D; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Skinner J; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA., Liang HE; Department of Medicine, University of California, San Francisco, San Francisco, California, USA., Schwer B; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA.; The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, San Francisco, California, USA.; Kavli Institute for Fundamental Neuroscience, University of California, San Francisco, San Francisco, California, USA., Okada H; Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA.; The Parker Institute for Cancer Immunotherapy, San Francisco, California, USA. |
| Source: | Neuro-oncology [Neuro Oncol] 2022 Feb 01; Vol. 24 (2), pp. 259-272. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
